284 results
Page 8 of 15
8-K
EX-99.1
f4e fzezw
30 Jul 19
NewLink Genetics Provides Corporate Update and Reports Second Quarter 2019 Financial Results
8:36am
S-3/A
3u6h t8ysms
1 Jul 19
Shelf registration (amended)
4:29pm
8-K
EX-99.1
m27xfabj4
23 May 19
NewLink Genetics Presents Updated NLG802 Results at the Immuno-Oncology 2019 World Congress
8:40am
8-K
EX-99.2
d3z8ws4m
8 May 19
NewLink Genetics Reports First Quarter 2019 Financial Results and Provides Clinical Activities Update
4:33pm
8-K
EX-99.1
la9ibfj
8 May 19
NewLink Genetics Reports First Quarter 2019 Financial Results and Provides Clinical Activities Update
4:33pm
8-K
EX-99.1
qlaw0ce4ulfr6t 7y
2 Apr 19
NewLink Genetics Presents Encouraging Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019
8:32am
8-K
EX-99.1
ifh jkyb44
27 Feb 19
NewLink Genetics Announces Clinical Trial Abstract Presentation at AACR Annual Meeting
5:15pm
8-K
EX-99.2
4pnjt7ntdneru 76cej
27 Feb 19
NewLink Genetics Reports Fourth Quarter, Year-End 2018 Financial Results and Provides Update for Clinical Programs
4:41pm
8-K
EX-99.1
6fjoaf58484
27 Feb 19
NewLink Genetics Reports Fourth Quarter, Year-End 2018 Financial Results and Provides Update for Clinical Programs
4:41pm
8-K
EX-99.1
uel8 mey01c
3 Dec 18
Other Events
4:35pm
8-K
EX-99.1
k2b3zej8aqei
15 Nov 18
In 2014 the Company entered into a license agreement with Merck to develop, manufacture and commercialize NewLink Genetics’ Ebola vaccine candidate
9:15am
8-K
EX-99.1
santio 7zlf9
9 Nov 18
Other Events
8:22am
8-K
EX-99.1
a1tkdwl0cos4hwys1u4
6 Nov 18
NewLink Genetics Announces Publication of Abstracts for Presentation at the Society for Immunotherapy for Cancer (SITC) Conference
9:09am